Prostate cancer screening still unproven: report (Reuters)

NEW YORK (Reuters Health) – PSA blood tests are often used to screen men for prostate cancer, but there is still no good evidence that they cut death rates from the disease, a new review finds. Based on two recent major clinical trials, the practice of routinely screening men with the PSA test has "at best" a small effect on deaths from prostate cancer, according to the review, published in CA: A Cancer Journal for Clinicians. The studies, which came out earlier this year in The New England Journal of Medicine, appear to bolster the positions of the American Cancer Society (ACS) and other major medical groups, which do not recommend routine PSA screening for symptom-free men at average risk of developing prostate cancer. PSA, or prostate-specific antigen, is a protein produced by the prostate gland, blood levels of which... [read full story]                    

powered by
Add Comment
There are also 41 related articles
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies